Knowledge Distillery

In this paper, recently published in Stroke, the authors aimed to compare anterior circulation large vessel occlusion stroke severity between patients…

Superspreading events (SSEs) have characterised previous epidemics of severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East…

The objective of this article recently published in Neurology Neuroimmunology & Neuroinflammation was to investigate the pathophysiological mechanism…

In this paper recently published in the European Journal of Neurology, the authors aimed to assess 1‐month outcome in ischaemic stroke patients with…

In this paper, the authors aimed to assess risk factors associated with intracerebral haemorrhage (ICH) in COVID-19 patients.

In this paper, the authors examined the frequency of acute intracranial abnormalities seen on cranial CT and/or MR imaging in patients with COVID-19…

Cerebral venous sinus thrombosis (CVST) with thrombocytopenia, a rare and serious condition, has been described in Europe following receipt of the…

The COVID-19 pandemic continues to affect millions of people globally, with increasing reports of neurological manifestations but limited data on…

During the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, neurological symptoms increasingly moved into the focus of interest.

This study assessed the prevalence and risk factors for SARS-CoV-2 infection in patients with epilepsy (PWE). Additionally, the course of COVID-19 and…

The Pfizer-BioNTech (BNT162b2) and the Oxford-AstraZeneca (ChAdOx1 nCoV-19) COVID-19 vaccines have shown excellent safety and efficacy in phase 3…

Two mRNA vaccines, BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna), received Emergency Use Authorization from the US Food and Drug Administration.…